MENU
ENGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
enGene Holdings (ENGN) Ownership - Who owns enGene Holdings?
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients... Show more
Profile
Industry
N/A
Address
7171 Rue Frederick Banting
Phone
+1 514 332-4888
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
168.14M
P/E Ratio
N/A
Total Cash
217.39M
Projected Growth
N/A
Total Debt
25.36M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.25
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ENGN
Capitalization
168M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
217M
Total Cash/Share
4.25
Total Debt
25.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
227M
P/B Ratio
0.74
Cash Flow
N/A
Earnings
-1.63
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
510M
Current Ratio
12.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-76.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.57
Shares Held By Institutions
193M
Shares Outstanding - Current
51.1M
Total Liabilities
39.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-50.526
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7171 Rue Frederick Banting
Phone
+1 514 332-4888
Employees
N/A
Web
N/A